Anand Business Co.
FDA import alert and refusal historyNew Dehli, IndiaFEI 3001082446
As of October 26, 2026, Anand Business Co. (New Dehli, India) is on the red list of FDA Import Alert 23-14 (Food products: mycotoxins) for peanut gajak (peanut brittle), published by FDA on February 3, 2011, and has no FDA import refusals recorded since October 2016.
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- IA 23-14 · red list
- Last import refusal
- None since October 2016
- Last warning letter
- None found
- Last inspection
- None on record
Every FDA record for Anand Business Co.
1 record, newest first. Each line links to the FDA page it came from.
2011
- Import alert listingListed on Import Alert 23-14red listPeanut Gajak (Peanut Brittle)Source
Questions about Anand Business Co.
- Is Anand Business Co. on an FDA import alert?
- Yes. As of October 26, 2026, Anand Business Co. is on the red list of FDA Import Alert 23-14, “Food products: mycotoxins”, for peanut gajak (peanut brittle); FDA published the listing on February 3, 2011.
- Has FDA refused shipments from Anand Business Co.?
- No FDA import refusals for Anand Business Co. appear in FDA's refusal data since October 2016, as of October 26, 2026.
- What is Anand Business Co.'s FEI number?
- Anand Business Co.'s FDA Establishment Identifier (FEI) is 3001082446.
- Can shipments from Anand Business Co. still enter the U.S.?
- Shipments of peanut gajak (peanut brittle) from Anand Business Co. can be detained without physical examination under Import Alert 23-14; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).
Buying from Anand Business Co.?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.